Skip to content
← Compound profiles
Image for the Phytotherapy compound group
Phytotherapy

Astaxanthin

Haematococcus pluvialis

Mechanism

Astaxanthin is a red carotenoid obtained primarily from the microalga Haematococcus pluvialis. In cell and human studies it shows a pronounced antioxidant capacity and protects cells, among other things, from oxidative stress; natural, ester-containing extracts act more strongly than synthetic astaxanthin. In the horse the data on clinical endpoints (e.g. exercise stress, recovery) are thin, and use is based predominantly on transfer from other species. Products differ markedly in source (natural vs. synthetic), content and bioavailability (formulation with oil).

Cautions

  • · Equine endpoint evidence is thin — transfer from human/in-vitro data
  • · Product quality strongly fluctuating (natural vs. synthetic, content, bioavailability)
  • · Demand the declared active content and a batch CoA

Sources

PMID:25962124Régnier et al. 2015 (Mar Drugs) — Astaxanthin aus Haematococcus pluvialis, antioxidativer Schutz (Zellstudie)
ReviewBioactive properties of astaxanthin from Haematococcus pluvialis (Antioxidans-Review)
EFSA AstaxanthinEFSA — Bewertung von Astaxanthin/Haematococcus als Futtermittelzusatz

Usage note

This content is for information and education. It does not replace veterinary diagnosis or treatment. If your horse shows signs of illness, consult a veterinarian.

“Nothing forced can ever be beautiful.”
Xenophon · On Horsemanship (c. 365 BC)

Equiterna is an intermediary platform for equine knowledge, marketplace and tools — not a veterinary-medicines dealer, veterinary practice or pharmacy. Compound information is study-attributed and free of healing claims. Legal framework: Regulation (EU) 2019/6 / TAMG (DE/AT), Feed Regulation (EC) 767/2009, FEI Prohibited Substances List, HWG.